Financial News

Gainers Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market session. The market value of their outstanding shares is at $8.2 million. Barinthus Biotherapeutics...

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 20, 2026

Via Benzinga

Performance

52-Week Range 50.7% below 52-week high

0.7401

0.5152W Low 1.5052W High

Barinthus Biotherapeutics plc - American Depositary Shares (BRNS) traded between $0.51 and $1.50 over the past 52 weeks and last traded at $0.74, 50.7% below its 52-week high.

Past 12 Months

N/A

+20.9%

+23.1%

+0.7%

-43.5%

3M +$0.13

6M +$0.14

YTD +$0.01

1Y -$0.57

BRNS was -43.5% over the past year, +23.1% over six months, +0.7% year to date.

12 Months vs Market

BRNS

-43.5%

DIA

+11.9%

SPY

+16.1%

QQQ

+21.1%

IWM

+11.0%

Over the past 12 months BRNS returned -43.5% versus DIA (Dow) +11.9%, SPY (S&P 500) +16.1%, QQQ (Nasdaq 100) +21.1% and IWM (Russell 2000) +11.0%.

Volume & Liquidity

52.2K

63.7K

YTD

55.7K

65.1K

BRNS's 3-month average daily volume is 52.2K.

More News

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 17, 2026

Via Benzinga

Barinthus Biotherapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Barinthus Biotherapeutics plc - BRNS

May 11, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Halper Sadeh LLC is Investigating Whether TBRG, SILA, BRNS are Obtaining Fair Deals for their Shareholders

April 30, 2026

Barinthus Bio Reports First Quarter 2026 Financial Results and Updates on Corporate Developments

April 30, 2026

Barinthus Bio Reports Full Year 2025 Financial Results and Updates on Corporate Developments

March 13, 2026

Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease

December 10, 2025

Halper Sadeh LLC Encourages HFWA, BRNS, FITB Shareholders to Contact the Firm to Discuss Their Rights

November 20, 2025

Halper Sadeh LLC Encourages HFWA, FITB, AVDL, BRNS Shareholders to Contact the Firm to Discuss Their Rights

November 18, 2025

Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments

Top movers in Monday's session ↗

November 10, 2025

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 10, 2025

Via Benzinga

November 07, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)

October 16, 2025

From Brodsky & Smith LLC

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates DAY, BRNS, ETNB, VRNT on Behalf of Shareholders

October 08, 2025

October 08, 2025

From Brodsky & Smith LLC

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VECO, BRNS, VRNT on Behalf of Shareholders

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 07, 2025

Via Benzinga

October 04, 2025

BARINTHUS BIOTHERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Barinthus Biotherapeutics plc - BRNS

October 03, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 01, 2025

Via Benzinga

BRNS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Barinthus Biotherapeutics plc Is Fair to Shareholders

September 30, 2025

Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases

Via Business Wire

Barinthus Biotherapeutics To Merge With Privately-Held Clywedog Therapeutics ↗

September 30, 2025

Via Stocktwits

September 30, 2025

Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate Developments

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 11, 2025

Via Benzinga

August 07, 2025